Skip Navigation

Publication Detail

Title: Exposure to inorganic arsenic and its methylated metabolites alters metabolomics profiles in INS-1 832/13 insulinoma cells and isolated pancreatic islets.

Authors: Li, Yuan-Yuan; Douillet, Christelle; Huang, Madelyn; Beck, Rowan; Sumner, Susan Jenkins; Styblo, Miroslav

Published In Arch Toxicol, (2020 Jun)

Abstract: Inorganic arsenic (iAs) is an environmental diabetogen, but mechanisms underlying its diabetogenic effects are poorly understood. Exposures to arsenite (iAsIII) and its methylated metabolites, methylarsonite (MAsIII) and dimethylarsinite (DMAsIII), have been shown to inhibit glucose-stimulated insulin secretion (GSIS) in pancreatic β-cells and isolated pancreatic islets. GSIS is regulated by complex mechanisms. Increase in ATP production through metabolism of glucose and other substrates is the ultimate trigger for GSIS in β-cells. In the present study, we used metabolomics to identify metabolites and pathways perturbed in cultured INS-1 832/13 rat insulinoma cells and isolated murine pancreatic islets by exposures to iAsIII, MAsIII and DMAsIII. We found that the exposures perturbed multiple metabolites, which were enriched primarily in the pathways of amino acid, carbohydrate, phospholipid and carnitine metabolism. However, the effects of arsenicals in INS-1 832/13 cells differed from those in the islets and were exposure specific with very few overlaps between the three arsenicals. In INS-1 832/13 cells, all three arsenicals decreased succinate, a metabolite of Krebs cycle, which provides substrates for ATP synthesis in mitochondria. Acetylcarnitine was decreased consistently by exposures to arsenicals in both the cells and the islets. Acetylcarnitine is usually found in equilibrium with acetyl-CoA, which is the central metabolite in the catabolism of macronutrients and the key substrate for Krebs cycle. It is also thought to play an antioxidant function in mitochondria. Thus, while each of the three trivalent arsenicals perturbed specific metabolic pathways, which may or may not be associated with GSIS, all three arsenicals appeared to impair mechanisms that support ATP production or antioxidant defense in mitochondria. These results suggest that impaired ATP production and/or mitochondrial dysfunction caused by oxidative stress may be the mechanisms underlying the inhibition of GSIS in β-cells exposed to trivalent arsenicals.

PubMed ID: 32277266 Exiting the NIEHS site

MeSH Terms: Adenosine Triphosphate/metabolism; Animals; Arsenites/metabolism; Arsenites/toxicity*; Biotransformation; Cacodylic Acid/analogs & derivatives*; Cacodylic Acid/metabolism; Cacodylic Acid/toxicity; Cell Line, Tumor; Energy Metabolism/drug effects*; Insulinoma/metabolism*; Insulinoma/pathology; Islets of Langerhans/drug effects*; Islets of Langerhans/metabolism; Islets of Langerhans/pathology; Male; Metabolome*; Metabolomics; Methylation; Mice, Inbred C57BL; Mitochondria/drug effects; Mitochondria/metabolism; Mitochondria/pathology; Oxidative Stress/drug effects; Pancreatic Neoplasms/metabolism*; Pancreatic Neoplasms/pathology; Rats; Tissue Culture Techniques

Back
to Top